Company profile for ABVC BioPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ABVC has targeted its business to the stage of drug development that moves promising drugs from the laboratory to the market, the translational phase. Drugs considered by ABVC are usually derived from plants, address significant illnesses, and have successfully completed pre-clinical, disease animal model and Phase I safety studies at world-class research institutions. After examination of the data associated with a new drug c...
ABVC has targeted its business to the stage of drug development that moves promising drugs from the laboratory to the market, the translational phase. Drugs considered by ABVC are usually derived from plants, address significant illnesses, and have successfully completed pre-clinical, disease animal model and Phase I safety studies at world-class research institutions. After examination of the data associated with a new drug candidate, ABVC enters into a licensing agreement with the research institutions, submits an application to the health authorities such as U.S. FDA, Australia TGA and Taiwan TFDA to begin Phase II trials.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
44370 Old Warm Springs Boulevard Fremont, California 94538
Telephone
Telephone
+1 845-291-1291
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2024/12/19/2999864/0/en/ABVC-BioPharma-Seeks-to-Revolutionize-Mental-Health-Treatment-With-a-Safe-Prozac-Alternative-Boasting-a-MADRS-Score-Reduction-of-13-21.html

GLOBENEWSWIRE
19 Dec 2024

https://www.globenewswire.com/news-release/2024/11/14/2981259/0/en/ABVC-BioPharma-Inc-Reports-Q3-2024-Financial-Results-and-Operational-Milestones.html

GLOBENEWSWIRE
14 Nov 2024

https://www.globenewswire.com/news-release/2024/10/22/2966962/0/en/ABVC-BioPharma-Receives-50-000-in-Incremental-Licensing-Fees-Boosting-Total-Payments-to-346-000-From-Its-Three-Strategic-Partners.html

GLOBENEWSWIRE
22 Oct 2024

https://www.globenewswire.com/news-release/2024/08/15/2930820/0/en/ABVC-BioPharma-Inc-Reports-Strong-Q2-2024-Financial-Results-and-Strategic-Achievements.html

GLOBENEWSWIRE
15 Aug 2024

https://www.accesswire.com/viewarticle.aspx?id=890145&lang=en

ACCESSWIRE
18 Jul 2024

https://www.globenewswire.com/news-release/2024/04/17/2864586/0/en/ABVC-BioPharma-Executes-a-Global-Licensing-Definitive-Agreement-for-the-Treatment-of-NSCLC-Expecting-Aggregate-Income-of-13-75M-and-Royalties-of-up-to-12-50M.html

GLOBENEWSWIRE
17 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty